相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

在老年癌症患者中综合癌症基因组分析测试的实用性

Hiroyuki Okuyama¹, Hiroki Sakuyama², Yoriyuki Tahara²

¹Department of Medical Oncology, Kagawa University Hospital, Miki, Japan.

|September 25, 2025

概括

综合癌症基因组分析 (CGP) 测试对老年癌症患者有益,显示年轻患者与年轻患者相同的治疗机会. 建议对老年人进行早期CGP测试,以确保及时启动治疗.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
老年医学老年医学

背景情况:

综合癌症基因组分析 (CGP) 测试于2019年在日本开放,在老年癌症患者中增加了其使用.
老年患者可能因伴随疾病和器官功能障碍而面临癌症治疗的挑战.
在老年癌症患者中调查CGP测试的实用性和挑战是至关重要的.

研究的目的:

评估综合癌症基因组分析 (CGP) 测试在老年癌症患者 (年龄≥75岁) 中的有用性.
为了比较老年人和非老年癌症患者之间的CGP测试结果.
确定与老年人群中CGP测试相关的挑战.

主要方法:

在2019年12月至2024年11月期间接受CGP测试的423名癌症患者的回顾性研究.
在老年人 (≥75岁) 和非老年患者组之间比较获得保险批准药物和临床试验的机会.
根据CGP结果评估治疗资格和参与.

主要成果:

在423名患者中,89人 (21%) 是老年人.
在老年人和非老年患者之间,在获得保险批准药物或临床试验的比例上没有发现显著差异.
少数老年患者由于一般状况不佳而无法接受治疗.

结论:

综合癌症基因组分析 (CGP) 测试是老年癌症患者的宝贵工具,为目标治疗和临床试验提供类似的访问.
建议在老年患者中早期实施CGP测试,以促进及时的治疗决策.
进一步开发更少的毒性疗法可以改善老年患者的治疗可用性,器官功能不佳.

关键词:

癌症基因组分析测试癌症基因组分析测试化疗化疗是一种化学疗法.老年患者的患者.

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...